Biorepository to Support Research in Kidney Diseases
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT04343417
- Status
- Enrolling By Invitation
Conditions
- Acute Interstitial Nephritis
- Acute Kidney Injury
- Kidney Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
To support advances in the understanding of pathophysiology and therapies of kidney diseases by creating a BioBank of kidney tissue, DNA, plasma, and urine from patients with kidney diseases.
Key Dates
- Start date
- Jul 28, 2020
- Status verified
- Aug 2025
- Primary completion
- Aug 1, 2030
- Completion
- Aug 1, 2035
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: BiorepositoryParticipants who contributed biospecimen samples (kidney tissue, blood, urine, DNA).
Primary Outcome Measure
Histological diagnosis [ Time Frame: 5 years ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale New Haven Hospital Saint Raphael Campus | New Haven | Connecticut | 06511 | - |
| Yale New Haven Hospital, York Street Campus | New Haven | Connecticut | 06510 | - |
Find similar trials in New Haven, CT
Related Studies
- A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI TrialRecruiting · University of Pittsburgh · Birmingham, Alabama
- Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0Enrolling By Invitation · Indiana University · Birmingham, Alabama
- Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal SyndromePHASE2 · Recruiting · Yale University · New Haven, Connecticut
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)Recruiting · The Rogosin Institute · New York, New York